Profit and Revenue Beat Estimates, Rise 29.6% and 17% Respectively

Income from US formulations business registered 31% growth to Rs 2,409.6 crore, although sequentially it was flat. US formulations business continued its upward trajectory with a formidable YoY growth, driven by volume expansion and new launches over last 12 months. The business accounted for…